Cargando…
Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
Introduction: Recent modifications in the epidemiology of oropharyngeal squamous cell carcinoma (OSCC) have led to the increase of Human papillomavirus (HPV) related metastatic head and neck cancer patients with high life expectancy even at advanced stage, low comorbidity and still restricted system...
Autores principales: | Modesto, Anouchka, Siegfried, Aurore, Lusque, Amelie, Vergez, Sébastien, Sarini, Jerome, Brouchet, Laurent, Uro-Coste, Emmanuelle, Graff-Cailleaud, Pierre, Delord, Jean Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161744/ https://www.ncbi.nlm.nih.gov/pubmed/33947015 http://dx.doi.org/10.3390/curroncol28030156 |
Ejemplares similares
-
The GIRAFE phase II trial on MVCT-based “volumes of the day” and “dose of the day” addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer()
por: Esteyrie, Vincent, et al.
Publicado: (2019) -
Cytochrome P450 1B1 polymorphism drives cancer cell stemness and patient outcome in head-and-neck carcinoma
por: Morvan, Valérie Le, et al.
Publicado: (2020) -
Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma
por: Saiyed, Faiez K., et al.
Publicado: (2021) -
Molecular predictors of locoregional and distant metastases in oropharyngeal squamous cell carcinoma
por: Barber, Brittany R, et al.
Publicado: (2013) -
Exploratory window‐of‐opportunity trial to investigate the tumor pharmacokinetics/pharmacodynamics of the IAP antagonist Debio 1143 in patients with head and neck cancer
por: Gomez‐Roca, Carlos, et al.
Publicado: (2021)